FUJIFILM Healthcare Americas Corporation

FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company dedicated to advancing healthcare providers' ability to deliver optimal care and improve patient outcomes. Its core business encompasses the detection, diagnosis, and treatment of diseases, with solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, in-vitro diagnostics, regenerative medicine, and life sciences. The company operates with a mission to "never stop innovating for a healthier world" and is headquartered in Lexington, Massachusetts.

The company offers a broad portfolio of products and services, including digital radiography, women's health solutions, ultrasound, MRI, and CT systems within diagnostic imaging. Its enterprise imaging solutions feature the Synapse Enterprise Imaging platform, Synapse RIS, and Synapse One. In endoscopic imaging, it provides endoscopes and advanced endobronchial ultrasound bronchoscopes, while surgical imaging includes Clinical 3D, C-Arms, and portable X-ray solutions. Additionally, FUJIFILM Healthcare Americas Corporation supplies in-vitro diagnostics, such as clinical diagnostic and research reagents and serum biomarker assays. These offerings serve a wide range of market segments, including hospitals, academic medical centers, independent ambulatory practices, clinical diagnostic laboratories, and government entities.

Led by President and CEO Henry Izawa, FUJIFILM Healthcare Americas Corporation maintains a strong market position through continuous innovation and strategic expansion. Recent developments include the opening of a new 18,000-square-foot warehouse in Fairfield, New Jersey, in May 2026, to enhance endoscopy operations and service capacity. The company has also forged partnerships, such as with mTuitive for precision medicine, and launched new products like the EB-710US endobronchial ultrasound bronchoscope. Its ELUXEO 8000® Endoscopic Imaging System received a 2026 MedTech Breakthrough Award, underscoring its commitment to advanced technology, including AI-driven solutions like the REiLI initiative, to optimize clinical workflows and improve patient care.